Sep 10, 2026, 4:44 PM1 views

WD-40: The 24% Third Quarter Growth Is Not The Starting Point

Markets

Seekingalpha Verified Source

Syndicated via official news feed

Read Full Story on Seekingalpha

Explore all Markets stories

Syndicated feed content with full publisher credit.

Markets Desk

More in Markets

Continue reading verified coverage and related developments on this desk.

View All

MARKETS2M AGO

Already up 137% in 1 year still JM Financial sees more upside in this stock | Check target price, shareholding pattern

With a staggering 137% rise in the past year, Acutaas Chemicals continues to draw attention from investors. JM Financial recently reinstated a buy rating with a target price of ₹3,800, indicating more potential growth.

MARKETS5M AGO

Nurix Therapeutics, Inc. (NRIX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Nurix Therapeutics, Inc. (NRIX) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 3:00 PM EDTCompany ParticipantsJason.

MARKETS5M AGO

Relay Therapeutics, Inc. (RLAY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks Transcript

Relay Therapeutics, Inc. (RLAY) Wells Fargo 21st Annual Healthcare Conference September 8, 2026 1:30 PM EDTCompany ParticipantsPeter.

MARKETS5M AGO

UnitedHealth Group Incorporated (UNH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

MARKETS6M AGO

Applied Optoelectronics Still Over Lumentum: Buying Back The Loser For A Better Reason

MARKETS6M AGO

More in Markets

Already up 137% in 1 year still JM Financial sees more upside in this stock | Check target price, shareholding pattern

Nurix Therapeutics, Inc. (NRIX) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Relay Therapeutics, Inc. (RLAY) Presents at Wells Fargo 21st Annual Healthcare Conference Prepared Remarks Transcript

UnitedHealth Group Incorporated (UNH) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript

Applied Optoelectronics Still Over Lumentum: Buying Back The Loser For A Better Reason

Enterprise Products Partners: A Dividend Champion With Imminent Breakout Potential